Crossmark

KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2

Crossref DOI link: https://doi.org/10.1186/s13148-018-0473-4

Published Online: 2018-04-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cocco, Elisa

Leo, Manuela

Canzonetta, Claudia

Di Vito, Serena

Mai, Antonello

Rotili, Dante

Di Napoli, Arianna

Vecchione, Andrea

De Nunzio, Cosimo

Filetici, Patrizia https://orcid.org/0000-0001-9459-7490
Stoppacciaro, Antonella
Funding

Funding for this research was provided by:

AIRC 2016 (IG16862)

MIUR-PRIN2016 (2TE5PK)

Shanghai Aircraft Manufacturing Company (19162)

MIUR-PRIN2011 (2010W4J4RM_004)

Sapienza Università di Roma (PhD Grant)
License Information

Text and Data Mining valid from 2018-04-04
More Information

Article History

Received: 16 January 2018

Accepted: 14 March 2018

First Online: 4 April 2018

Ethics approval and consent to participate

: The use of the histological material was authorized by personal patient consensus according to S. Andrea Hospital policy form.

: All authors approved the publication of the submitted paper.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.